Abbott To Pay $1.6 Billion To Settle Depakote Probes

In the second-largest such settlement by a drugmaker, Abbott Laboratories has agreed to pay $1.6 billion to resolve various probes into the marketing of its Depakote seizure med. The drug and device m…
Read the full story: Pharmalot